Physician Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arastirma Hastanesi, Van
Global fibrinolytic capacity increased in metastatic colorectal cancer
June 22nd, 2005
Scientists claimed that global fibrinolytic capacity (GFC) increased exponentially in metastatic colorectal cancer. "Colorectal cancers are one of the most common malignancies associated with coagulation abnormalities ranging from asymptomatic laboratory changes to massive thromboembolism or hemorrhage. It was previously shown that global fibrinolytic was increased in non-metastatic colorectal cancer," investigators in Turkey reported. "In this study global fibrinolytic capacity was measured in patients with colorectal cancer and metastatic liver disease, which always more commonly displays various coagulation disorders," explained C. Kockar and...
Source: Physician Law Weekly (2005-06-22)
|
